Global Somatostatin Analogs Market

Mayurikathade08 Oct, 2020Business

Global Somatostatin Analogs Market size was valued at US$ XX Bn. in 2019 and the total revenue is expected to grow at a CAGR of 7.3% from 2020 to 2027, reaching nearly US$ XX Bn. Global Somatostatin Analogs Market The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of Market leaders, Market followers, and Market disrupters in the report, and the same is reflected in our analysis. Definition: Somatostatin Analogs are the artificial version of Somatostatin that helps control the excessive secretion of hormones, especially the growth hormone and serotonin in the human body. It is commonly used to treat Neuroendocrine Tumors (NETs) and Acromegaly, a rare hormonal disorder, and other such hormonal disorders.